Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 6, 1996, Pages 784-793

  Sevanian, Alex ^a,b   Hwang, Juliana ^a   Hodis, Howard ^a,b   Cazzolato, Giuseppe ^c   Avogaro, Pietro ^d   Bittolo Bon, Gabriele ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Ospedale Riuniti   (Italy)

^d NONE

Author keywords

ascorbic acid; heme; lipid peroxidation; peroxides

Indexed keywords

COPPER; HEME; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN;

ADULT; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; ATHEROSCLEROSIS; HUMAN; LIPID PEROXIDATION; OXIDATION; PRIORITY JOURNAL; RISK; ULTRACENTRIFUGATION;

EID: 0030006777     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.6.784     Document Type: Article

References (55)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JI. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
2. Esterbauer H, Jurgens G, Quehenberger O, Koller E. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res. 1987;28:495-509.
3. Messier JR, Morel DW, Lewis LJ, Chisolm GM. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis. 1983;3:215-222.
4. Morel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low-density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 1984;4:357-364.
5. Hodis HN, Kramsch DM, Avogaro P, Bittolo-Bon G, Cazzolato G, Hwang J, Peterson H, Sevanian A. Biochemical and cytotoxic characteristics of an in vitro circulating oxidized LDL. J Lipid Res. 1994;35:669-677.
6. Cazzolato G, Avogaro P, Bittolo-Bon G. Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC. Free Radic Biol Med. 1991;11:247-253.
7. Avogaro P, Bittolo-Bon G, Cazzolato G. Presence of modified low-density lipoprotein in humans. Arteriosclerosis. 1988;8:79-87.
8. Tyroler HA. Review of lipid-lowering clinical trials in relation to observational epidemiologic studies. Circulation. 1987;76:515-522.
9. Savenkova MI, Mueller DM, Heinecke J. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J Biol Chem. 1994;269:20394-20400.
10. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial Superoxide anion production. J Clin Invest. 1993;91:2546-2551.
11. Shimano H, Yamada N, Ishibashi S, Hiroshi H, Mori N, Gotoda T, Harada K, Akanuama Y, Murase T, Yazaki Y, Takaku F. Oxidation-labile subfraction of human plasma low density lipoprotein isolated by ion exchange chromatography. J Lipid Res. 1991;32:763-770.
12. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim J, Bamshad B, Esterson M, Fogelman AM. Minimally modified LDL stimulates monocyte-endothelial interactions. J Clin Invest. 1990;85:1260-1266.
13. Avogaro P, Cazzolato G, Bittolo-Bon G. Some questions concerning a small, more electronegative LDL circulating in human plasma. Atherosclerosis. 1991;91:163-166.
14. Shen MS, Krauss RM, Lindgren FT, Forte TM. Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res. 1981;22:236-242.
15. Nelson CA, Morris MD. The ultracentrifugal heterogeneity of low density lipoproteins in normal humans. Biochem Med. 1977;18:1-8.
16. Kirchenhausen TG, Fless G, Scanu AM. The ultracentrifugal heterogeneity of low density lipoproteins: experimental facts and interpretation: a minireview. Lipids. 1980;15:464-467.
17. Sundaram SG, Shakir KMM, Margolis S. Preparative isoelectric focusing of human very low-density and low density lipoproteins. Anal Biochem. 1978;88:425-429.
18. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willette WC, Krauss RM. Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260:1917-1921.
19. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 1982;23:97-104.
20. Nichols AV, Krauss RM, Musliner TA. Nondenaturating polyacrylamide gradient gel electrophoresis. Methods Enzymol. 1986;128:417-426.
21. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PWF, Schaefer EJ. Effect of gender, age, and lipid status on low-density lipoprotein subfraction distribution: results of the Framingham Offspring Study. Arteriosclerosis. 1987;7:483-497.
22. Austin MA, King MC, Vranizan KM, Newman B, Krauss RM. Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet. 1988;43:838-846.
23. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions differing in density and particle size. Atherosclerosis. 1992;93:189-199.
24. Lipid Research Clinics Program. The Manual of Laboratory Operations: Lipids and Lipoprotein Analysis. Bethesda, Md: National Institutes of Health; 1974. Dept of Health, Education, and Welfare publication NIH 75-628.
25. Laurell CB. Electroimmunoassay. Scand J Clin Lab Invest. 1972;29(suppl 124):21-37.
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
27. Kim E, Sevanian A. Hematin and peroxide catalyzed peroxidation of phospholipid liposomes. Arch Biochem Biophys. 1991;288:324-330.
28. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 1992;13:341-390.
29. Sattler W, Maiorino M, Stocker R. Reduction of HDL- and LDL-associated cholesteryl-ester and phospholipid hydroperoxides by phospholipid hydroperoxide glutathione peroxidase and ebselen (PZ51). Arch Biochem Biophys. 1994;309:214-221.
30. Corongiu FP, Banni S, Dessi MA. Conjugated dienes detected in tissue lipid extracts by second derivative spectroscopy. Free Radic Biol Med. 1989;7:183-186.
31. Pacifici EHK, McLeod LL, Peterson H, Sevanian A. Linoleic acid hydroperoxide-induced peroxidation of endothelial cell phospholipids and cytotoxicity. Free Radic Biol Med. 1994;17:285-295.
32. Auerbach BJ, Kiely JS, Cornicelli JA. A spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid. Anal Biochem. 1992;201:375-380.
33. Bieri JG, Tolliver TJ, Catignani GL. Simultaneous determination of α-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography. Am J Clin Nutr. 1979;32:2143-2149.
34. Thomas CE, Jackson RL. Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins. J Pharmacol Exp Ther. 1991;256:1182-1188.
35. Maiorino M, Zamburlini A, Roveri A, Ursini F. Copper-induced lipid peroxidation in liposomes, micelles, and LDL: which is the role of vitamin E? Free Radic Biol Med. 1995;18:67-74.
36. Muller A, Cadenas E, Graf P, Sies H. A novel biologically active seleno-organic compound, I: glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ51 (ebselen). Biochem Pharmacol. 1984;33:3235-3239.
37. Ingold KU, Bowry VW, Stocker R, Walling C. Autoxidation of lipids and antioxidation by α-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein. Proc Natl Acad Sci USA. 1993;90:45-49.
38. Kagan VE, Serbinova EA, Forte T, Scita A, Packer L. Recycling of vitamin E in human low density lipoproteins. J Lipid Res, 1992;33:385-397.
39. Tertov VV, Sobenin IA, Gabbasov ZA, Popov EG, Jaakkola O, Solakivi T, Nikkari T, Smirnov VN, Orekhov AN. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation: isolation, fractionation and characterization. Lab Invest. 1992;67:665-675.
40. O'Leary VJ, Darley-Usmar VM, Russel LJ, Stone D. Pro-oxidant effects of lipoxygenase-derived peroxides on the copper-initiated oxidation of low density lipoprotein. Biochem J. 1992;282:631-634.
41. 2+-stimulated oxidation of low-density lipoprotein. Arch Biochem Biophys. 1994;315:244-254.
42. Belcher JD, Balla J, Balla G, Jacobs DR, Gross M, Jacob HS, Vercellotti GM. Vitamin E, LDL, and endothelium: brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. Arterioscler Thromb. 1993;13:1779-1789.
43. Galaris D, Sevanian A, Cadenas E, Hochstein P. Ferrylmyoglobin-catalyzed linoleic acid peroxidation. Arch Biochem Biophys. 1990;281:163-169.
44. Reaven PD, Grasse BJ, Tribble DL. Effects of linoleate-enriched and oleate-enriched diets in combination with α-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Arterioscler Thromb. 1994;14:557-566.
45. Chait A, Brazg RL, Tribble DL. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with atherogenic lipoprotein phenotype, pattern B. Am J Med. 1993;94:350-356.
46. Dejager S, Bruckert E, Chapman JM. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res. 1993;34:295-308.
47. Barbosa DS, Maranhao RC, Araujo FB, Chang YH, Hirata MH, Abdalla DSP. Sialic acid and oxidizability of low density lipoprotein subfractions of hyperlipidemic patients. Clin Biochem. 1995;28:435-441.
48. Tribble DL, Thiel PM, van den Berg JJM, Krauss RM. Differing α-tocopherol oxidative lability and ascorbic acid-sparing effects in buoyant and dense LDL. Arterioscler Thromb Vase Biol. 1995;15:2025-2031.
49. Sutherland WHF. Oxidation of heparin-isolated LDL by hemin: the effect of serum components. Arterioscler Thromb. 1994;14:1966-1975.
50. Jialal I, Vega GL, Grundy SM. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis. 1990;82:185-191.
51. Balla G, Jacob HS, Eaton JW, Belcher JD, Vercellotti GM. Hemin: a possible physiological mediator of low-density lipoprotein oxidation and endothelial injury. Arterioscler Thromb. 1991;11:1700-1711.
52. Reaven PD, Witztum JL. Comparison of supplementation of RRR-α-tocopherol and racemic α-tocopherol in humans: effects on lipid levels and lipoprotein susceptibility to oxidation. Arterioscler Thromb. 1993;13:601-608.
53. Maiorino M, Coassin M, Roveri A, Ursini F. Microsomal lipid peroxidation: effect of vitamin E and its functional interaction with phospholipid hydroperoxide glutathione peroxidase. Lipids. 1989;24:721-726.
54. Martell AE. Chelates of ascorbic acid. In: Seib PA, Tolbert BM, eds. Ascorbic Acid: Chemistry, Metabolism and Uses. Washington, DC: American Chemical Society; 1982:153-178. Advances in Chemistry Series 200.
55. De Graaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PMN, Hendrik JCM, Stalenhoef AFH. Enhanced susceptibility to in vitro oxidation of the dense low-density lipoprotein fraction in healthy subjects. Arteriosclerosis. 1991;11:298-306.